TOMORROW'S MEDICINES TODAY

Ovarian cancer

Showing all 10 results

Read more
Ovarian cancer
Apnat 60 Mg
Rated 0 out of 5
Read more
Breast Cancer
Gembine Injection
Rated 0 out of 5
Read more
Breast Cancer
Lipodox 50 Injection
Rated 0 out of 5
Read more
Breast Cancer
LYNPARZA 150 MG ( OLAPARIB )
Rated 0 out of 5
Read more
Breast Cancer
Lynza 100 Mg
Rated 0 out of 5
Read more
Breast Cancer
Lynza 150 Mg
Rated 0 out of 5
Read more
Breast Cancer
Nudoxa Injection
Rated 0 out of 5
Read more
Breast Cancer
OBRENZA 150 MG ( OLAPARIB )
Rated 0 out of 5
Read more
Breast Cancer
VITRAKVI CAPSULE ( LAROTRECTINIB )
Rated 0 out of 5
Read more
Ovarian cancer
ZEJULA 100 MG (NIRAPARIB)
Rated 0 out of 5

We are committed to the Ethical Principles of the World Medical Association.

We are registered and audited by the Dutch Ministry of Health in The Hague as an Independent Intermediary for Medicines, registration number 6730 BEM and as a Pharmaceutical Distributor with the registration number 16258 G.

We support the United Nation’s 2030 Sustainable Development Goals related to Health and Equality.

ABOUT US

As a social impact enterprise, our core values are all about supporting Health, Freedom, and Opportunity.

(c) 2020 All Rights Reserved.

MENU

SOCIAL